The new treatments are Veoza (fezolinetant), which is approved for moderate to severe hot flashes and night sweats, and elinkinetant (Lynkuet), another non-hormonal medication recently approved n Australia. Both work by targeting the brain's temperature control center, not through hormones, but by blocking neurokinin B (NKB) receptors.









